Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series.

Anghileri E, Schettino C, Pollo B, Farinotti M, Silvani A, Paterra R, Patanè M, DiMeco F, Bruzzone MG, Eoli M, Cuccarini V.

Neurol Sci. 2020 Feb 29. doi: 10.1007/s10072-020-04288-7. [Epub ahead of print]

PMID:
32114667
2.

Peri-operative prognostic factors for primary skull base chordomas: results from a single-center cohort.

La Corte E, Broggi M, Raggi A, Schiavolin S, Acerbi F, Danesi G, Farinotti M, Felisati G, Maccari A, Pollo B, Saini M, Toppo C, Valvo F, Ghidoni R, Bruzzone MG, DiMeco F, Ferroli P.

Acta Neurochir (Wien). 2020 Jan 16. doi: 10.1007/s00701-020-04219-7. [Epub ahead of print]

PMID:
31950268
3.

In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting.

Cuccarini V, Antelmi L, Pollo B, Paterra R, Calatozzolo C, Nigri A, DiMeco F, Eoli M, Finocchiaro G, Brenna G, Tramacere I, Bruzzone MG, Anghileri E.

Neurol Sci. 2020 Feb;41(2):347-355. doi: 10.1007/s10072-019-04087-9. Epub 2019 Oct 24.

PMID:
31650436
4.

Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.

La Corte E, Dei Cas M, Raggi A, Patanè M, Broggi M, Schiavolin S, Calatozzolo C, Pollo B, Pipolo C, Bruzzone MG, Campisi G, Paroni R, Ghidoni R, Ferroli P.

Int J Mol Sci. 2019 Sep 11;20(18). pii: E4480. doi: 10.3390/ijms20184480.

5.

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.

Nehama D, Di Ianni N, Musio S, Du H, Patané M, Pollo B, Finocchiaro G, Park JJH, Dunn DE, Edwards DS, Damrauer JS, Hudson H, Floyd SR, Ferrone S, Savoldo B, Pellegatta S, Dotti G.

EBioMedicine. 2019 Sep;47:33-43. doi: 10.1016/j.ebiom.2019.08.030. Epub 2019 Aug 26.

6.

Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy.

Alessandri G, Coccè V, Pastorino F, Paroni R, Dei Cas M, Restelli F, Pollo B, Gatti L, Tremolada C, Berenzi A, Parati E, Brini AT, Bondiolotti G, Ponzoni M, Pessina A.

J Control Release. 2019 May 28;302:2-18. doi: 10.1016/j.jconrel.2019.03.016. Epub 2019 Mar 16.

PMID:
30890444
7.

Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.

Minasi S, Baldi C, Pietsch T, Donofrio V, Pollo B, Antonelli M, Massimino M, Giangaspero F, Buttarelli FR.

J Neurooncol. 2019 May;142(3):435-444. doi: 10.1007/s11060-019-03127-w. Epub 2019 Mar 4.

PMID:
30830680
8.

The β- radio-guided surgery: Method to estimate the minimum injectable activity from ex-vivo test.

Russomando A, Schiariti M, Bocci V, Colandrea M, Collamati F, Cremonesi M, Ferrari ME, Ferroli P, Ghielmetti F, Ghisini R, Grana CM, Mancini Terracciano C, Marafini M, Mirabelli R, Morganti S, Papi S, Patanè M, Pedroli G, Pollo B, Solfaroli Camillocci E, Traini G, Faccini R.

Phys Med. 2019 Feb;58:114-120. doi: 10.1016/j.ejmp.2019.02.004. Epub 2019 Feb 16.

PMID:
30824142
9.

Sleeve-Shaped Neurothekeoma of the Ulnar Nerve: A Unique Case of a Still Unclear Pathological Entity.

Vetrano IG, Levi V, Pollo B, Chiapparini L, Messina G, Nazzi V.

Hand (N Y). 2020 Jan;15(1):NP7-NP10. doi: 10.1177/1558944719828008. Epub 2019 Feb 14.

PMID:
30762430
10.

Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.

Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, Koelsche C, Sievers P, Wefers AK, Reinhardt A, Ebrahimi A, Fernández-Klett F, Pusch S, Meier J, Schweizer L, Paulus W, Prinz M, Hartmann C, Plate KH, Reifenberger G, Pietsch T, Varlet P, Pagès M, Schüller U, Scheie D, de Stricker K, Frank S, Hench J, Pollo B, Brandner S, Unterberg A, Pfister SM, Jones DTW, Korshunov A, Wick W, Capper D, Blümcke I, von Deimling A, Bertero L.

Acta Neuropathol. 2019 May;137(5):837-846. doi: 10.1007/s00401-019-01969-2. Epub 2019 Feb 13.

PMID:
30759284
11.

5-ALA Fluorescence in Case of Brain Abscess by Aggregatibacter Mimicking Glioblastoma.

de Laurentis C, Del Bene M, Fociani P, Tonello C, Pollo B, DiMeco F.

World Neurosurg. 2019 May;125:175-178. doi: 10.1016/j.wneu.2019.01.190. Epub 2019 Feb 8.

PMID:
30743027
12.

Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.

Bertero L, Dalla Dea G, Osella-Abate S, Botta C, Castellano I, Morra I, Pollo B, Calatozzolo C, Patriarca S, Mantovani C, Rudà R, Tardivo V, Zenga F, Garbossa D, Papotti M, Soffietti R, Ricardi U, Cassoni P.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):248-256. doi: 10.1093/jnen/nly127.

13.

Neuro-Behçet's disease presenting as an isolated progressive cognitive and behavioral syndrome.

Saracino D, Allegorico L, Barbarulo AM, Pollo B, Giaccone G, D'Amico A, D'Incerti L, Bugiani O, Di Iorio G, Sampaolo S, Melone MAB.

Neurocase. 2018 Oct - Dec;24(5-6):238-241. doi: 10.1080/13554794.2018.1561898. Epub 2018 Dec 25.

PMID:
30583716
14.

Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.

Corbetta C, Di Ianni N, Bruzzone MG, Patanè M, Pollo B, Cantini G, Cominelli M, Zucca I, Pisati F, Poliani PL, Finocchiaro G, Pellegatta S.

Int J Cancer. 2019 May 15;144(10):2539-2554. doi: 10.1002/ijc.31985. Epub 2019 Jan 5.

PMID:
30418668
15.

Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.

Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L.

J Neurooncol. 2018 Jul;138(3):679-680. doi: 10.1007/s11060-018-2893-6.

PMID:
29767306
16.

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.

Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S, Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L, Parati EA, Bruzzone MG, Finocchiaro G.

Oncoimmunology. 2018 Jan 29;7(4):e1412901. doi: 10.1080/2162402X.2017.1412901. eCollection 2018.

17.

Extensive and systematic rewiring of histone post-translational modifications in cancer model systems.

Noberini R, Osti D, Miccolo C, Richichi C, Lupia M, Corleone G, Hong SP, Colombo P, Pollo B, Fornasari L, Pruneri G, Magnani L, Cavallaro U, Chiocca S, Minucci S, Pelicci G, Bonaldi T.

Nucleic Acids Res. 2018 May 4;46(8):3817-3832. doi: 10.1093/nar/gky224.

18.

Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.

Pellegatta S, Savoldo B, Di Ianni N, Corbetta C, Chen Y, Patané M, Sun C, Pollo B, Ferrone S, DiMeco F, Finocchiaro G, Dotti G.

Sci Transl Med. 2018 Feb 28;10(430). pii: eaao2731. doi: 10.1126/scitranslmed.aao2731. Erratum in: Sci Transl Med. 2018 Apr 4;10 (435):.

PMID:
29491184
19.

Microglia immunophenotyping in gliomas.

Annovazzi L, Mellai M, Bovio E, Mazzetti S, Pollo B, Schiffer D.

Oncol Lett. 2018 Jan;15(1):998-1006. doi: 10.3892/ol.2017.7386. Epub 2017 Nov 9.

20.

Unique combination of myxopapillary ependymoma and conus lipoma with subcutaneous extension in an 11-month-old child.

Vetrano IG, Erbetta A, Pollo B, Saletti V, Valentini LG.

Childs Nerv Syst. 2018 Apr;34(4):597-599. doi: 10.1007/s00381-018-3738-5. Epub 2018 Jan 29. No abstract available.

PMID:
29380114
21.

Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.

Gessi M, Giagnacovo M, Modena P, Elefante G, Gianno F, Buttarelli FR, Arcella A, Donofrio V, Diomedi Camassei F, Nozza P, Morra I, Massimino M, Pollo B, Giangaspero F, Antonelli M.

Am J Surg Pathol. 2019 Jan;43(1):56-63. doi: 10.1097/PAS.0000000000000979.

PMID:
29266023
22.

Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease.

Chiapparini L, Cavalli G, Langella T, Venerando A, De Luca G, Raspante S, Marotta G, Pollo B, Lauria G, Cangi MG, Gerevini S, Botturi A, Pareyson D, Dagna L, Salsano E.

J Neurol. 2018 Feb;265(2):273-284. doi: 10.1007/s00415-017-8692-8. Epub 2017 Dec 4.

PMID:
29204962
23.

Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.

Schettino C, Caranci F, Lus G, Signoriello E, Eoli M, Anghileri E, Pollo B, Melone MAB, Di Iorio G, Finocchiaro G, Ugga L, Tedeschi E.

Quant Imaging Med Surg. 2017 Oct;7(5):592-597. doi: 10.21037/qims.2017.06.09.

24.

Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO).

Acerbi F, Broggi M, Schebesch KM, Höhne J, Cavallo C, De Laurentis C, Eoli M, Anghileri E, Servida M, Boffano C, Pollo B, Schiariti M, Visintini S, Montomoli C, Bosio L, La Corte E, Broggi G, Brawanski A, Ferroli P.

Clin Cancer Res. 2018 Jan 1;24(1):52-61. doi: 10.1158/1078-0432.CCR-17-1184. Epub 2017 Oct 10.

25.

Mutations targeting the coagulation pathway are enriched in brain metastases.

Richichi C, Fornasari L, Melloni GEM, Brescia P, Patanè M, Del Bene M, Mustafa DAM, Kros JM, Pollo B, Pruneri G, Sciandivasci A, Munzone E, DiMeco F, Pelicci PG, Riva L, Pelicci G.

Sci Rep. 2017 Jul 26;7(1):6573. doi: 10.1038/s41598-017-06811-x.

26.

First ex vivo validation of a radioguided surgery technique with β-radiation.

Solfaroli Camillocci E, Schiariti M, Bocci V, Carollo A, Chiodi G, Colandrea M, Collamati F, Cremonesi M, Donnarumma R, Ferrari ME, Ferroli P, Ghielmetti F, Grana CM, Mancini Terracciano C, Marafini M, Morganti S, Patanè M, Pedroli G, Pollo B, Recchia L, Russomando A, Toppi M, Traini G, Faccini R.

Phys Med. 2016 Sep;32(9):1139-44. doi: 10.1016/j.ejmp.2016.08.018. Epub 2016 Sep 2.

PMID:
27601248
27.

Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness.

Richichi C, Osti D, Del Bene M, Fornasari L, Patanè M, Pollo B, DiMeco F, Pelicci G.

Oncotarget. 2016 Nov 1;7(44):71491-71503. doi: 10.18632/oncotarget.11600.

28.

A case of medulloblastoma in adult patient affected by anaplastic oligoastrocytoma.

Simonetti G, Gaviani P, Lamperti E, Innocenti A, Botturi A, Saini M, Pollo B, Silvani A.

Neurol Sci. 2016 Oct;37(10):1727-30. doi: 10.1007/s10072-016-2640-8. Epub 2016 Jun 21.

PMID:
27329275
29.

Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

Massimino M, Miceli R, Giangaspero F, Boschetti L, Modena P, Antonelli M, Ferroli P, Bertin D, Pecori E, Valentini L, Biassoni V, Garrè ML, Schiavello E, Sardi I, Cama A, Viscardi E, Scarzello G, Scoccianti S, Mascarin M, Quaglietta L, Cinalli G, Diletto B, Genitori L, Peretta P, Mussano A, Buccoliero A, Calareso G, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Giombelli E, La Spina M, Buttarelli FR, Pollo B, Gandola L.

Neuro Oncol. 2016 Oct;18(10):1451-60. doi: 10.1093/neuonc/now108. Epub 2016 May 18.

30.

Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.

Mercurio L, Ajmone-Cat MA, Cecchetti S, Ricci A, Bozzuto G, Molinari A, Manni I, Pollo B, Scala S, Carpinelli G, Minghetti L.

J Exp Clin Cancer Res. 2016 Mar 25;35:55. doi: 10.1186/s13046-016-0326-y.

31.

Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection.

Prada F, Bene MD, Fornaro R, Vetrano IG, Martegani A, Aiani L, Sconfienza LM, Mauri G, Solbiati L, Pollo B, DiMeco F.

Neurosurg Focus. 2016 Mar;40(3):E7. doi: 10.3171/2015.11.FOCUS15573.

32.

Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Cuccarini V, Erbetta A, Farinotti M, Cuppini L, Ghielmetti F, Pollo B, Di Meco F, Grisoli M, Filippini G, Finocchiaro G, Bruzzone MG, Eoli M.

J Neurooncol. 2016 Jan;126(2):279-88.

PMID:
26468137
33.

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, Finocchiaro G, Friedman W, Fulop J, Gardner J, Hermes B, Herold-Mende C, Jungk C, Kendler A, Lehman NL, Lipp E, Liu O, Mandt R, McGraw M, Mclendon R, McPherson C, Neder L, Nguyen P, Noss A, Nunziata R, Ostrom QT, Palmer C, Perin A, Pollo B, Potapov A, Potapova O, Rathmell WK, Rotin D, Scarpace L, Schilero C, Senecal K, Shimmel K, Shurkhay V, Sifri S, Singh R, Sloan AE, Smolenski K, Staugaitis SM, Steele R, Thorne L, Tirapelli DP, Unterberg A, Vallurupalli M, Wang Y, Warnick R, Williams F, Wolinsky Y, Bell S, Rosenberg M, Stewart C, Huang F, Grimsby JL, Radenbaugh AJ, Zhang J.

N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.

34.

Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.

Kros JM, Huizer K, Hernández-Laín A, Marucci G, Michotte A, Pollo B, Rushing EJ, Ribalta T, French P, Jaminé D, Bekka N, Lacombe D, van den Bent MJ, Gorlia T.

J Clin Oncol. 2015 Jun 10;33(17):1943-50. doi: 10.1200/JCO.2014.59.0166. Epub 2015 Apr 27.

PMID:
25918297
35.

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.

Pellegatta S, Valletta L, Corbetta C, Patanè M, Zucca I, Riccardi Sirtori F, Bruzzone MG, Fogliatto G, Isacchi A, Pollo B, Finocchiaro G.

Acta Neuropathol Commun. 2015 Jan 21;3:4. doi: 10.1186/s40478-014-0180-0.

36.

Primary central nervous system angiosarcoma: a case report and literature review.

La Corte E, Acerbi F, Schiariti M, Broggi M, Maderna E, Pollo B, Nunziata R, Maccagnano E, Ferroli P.

Neuropathology. 2015 Apr;35(2):184-91. doi: 10.1111/neup.12178. Epub 2014 Nov 11. Review.

PMID:
25388456
37.

Neuritis ossificans.

Ferroli P, Franzini A, Broggi M, Acerbi F, Maderna E, Pollo B, Broggi G.

J Neurosurg. 2014 Nov;121(5):1287-8. doi: 10.3171/2010.8.JNS101289. Epub 2014 Sep 12. No abstract available.

PMID:
25216064
38.

Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.

Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L.

J Neurooncol. 2014 Jun;118(2):305-312. doi: 10.1007/s11060-014-1428-z. Epub 2014 Apr 3. Erratum in: J Neurooncol. 2018 May 16;:.

PMID:
24696052
39.

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

Acerbi F, Broggi M, Eoli M, Anghileri E, Cavallo C, Boffano C, Cordella R, Cuppini L, Pollo B, Schiariti M, Visintini S, Orsi C, La Corte E, Broggi G, Ferroli P.

Neurosurg Focus. 2014 Feb;36(2):E5. doi: 10.3171/2013.11.FOCUS13487.

40.

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.

Nava F, Tramacere I, Fittipaldo A, Bruzzone MG, Dimeco F, Fariselli L, Finocchiaro G, Pollo B, Salmaggi A, Silvani A, Farinotti M, Filippini G.

Neuro Oncol. 2014 May;16(5):719-27. doi: 10.1093/neuonc/not316. Epub 2014 Jan 23.

41.

Preoperative embolization of carotid chemodectoma: a technical challenge that can be customized according to angioarchitecture. Illustrative cases.

Faragò G, Castellani C, Ponzi S, Jankovic C, Saginario V, Berardi C, Pollo B, Ciceri EF.

Neuroradiol J. 2013 Dec;26(6):678-82. Epub 2013 Dec 18.

42.

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.

Patanè M, Porrati P, Bottega E, Morosini S, Cantini G, Girgenti V, Rizzo A, Eoli M, Pollo B, Sciacca FL, Pellegatta S, Finocchiaro G.

Mol Cancer. 2013 Dec 11;12:160. doi: 10.1186/1476-4598-12-160.

43.

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.

Pellegatta S, Eoli M, Frigerio S, Antozzi C, Bruzzone MG, Cantini G, Nava S, Anghileri E, Cuppini L, Cuccarini V, Ciusani E, Dossena M, Pollo B, Mantegazza R, Parati EA, Finocchiaro G.

Oncoimmunology. 2013 Mar 1;2(3):e23401.

44.

Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases.

Acerbi F, Broggi M, Eoli M, Anghileri E, Cuppini L, Pollo B, Schiariti M, Visintini S, Orsi C, Franzini A, Broggi G, Ferroli P.

Acta Neurochir (Wien). 2013 Jul;155(7):1277-86. doi: 10.1007/s00701-013-1734-9. Epub 2013 May 10.

PMID:
23661063
45.

Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.

Gaviani P, Corsini E, Salmaggi A, Lamperti E, Botturi A, Erbetta A, Milanesi I, Legnani F, Pollo B, Silvani A.

Neurol Sci. 2013 Dec;34(12):2151-7. doi: 10.1007/s10072-013-1358-0. Epub 2013 Mar 24.

PMID:
23525755
46.

Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.

Modena P, Sardi I, Brenca M, Giunti L, Buccoliero AM, Pollo B, Biassoni V, Genitori L, Antonelli M, Maestro R, Giangaspero F, Massimino M.

BMC Cancer. 2013 Mar 5;13:100. doi: 10.1186/1471-2407-13-100.

47.

Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.

Salmaggi A, Milanesi I, Silvani A, Gaviani P, Marchetti M, Fariselli L, Solero CL, Maccagnano C, Casali C, Guzzetti S, Pollo B, Ciusani E, Dimeco F.

J Neurosurg. 2013 Apr;118(4):821-9. doi: 10.3171/2012.12.JNS111893. Epub 2013 Jan 25.

48.

An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.

Nava S, Dossena M, Pogliani S, Pellegatta S, Antozzi C, Baggi F, Gellera C, Pollo B, Parati EA, Finocchiaro G, Frigerio S.

PLoS One. 2012;7(12):e52301. doi: 10.1371/journal.pone.0052301. Epub 2012 Dec 20.

49.

Multidrug resistance proteins expression in glioma patients with epilepsy.

Calatozzolo C, Pollo B, Botturi A, Dinapoli L, Carosi M, Salmaggi A, Maschio M.

J Neurooncol. 2012 Oct;110(1):129-35. doi: 10.1007/s11060-012-0946-9. Epub 2012 Jul 26.

PMID:
22832898
50.

The MET oncogene is a functional marker of a glioblastoma stem cell subtype.

De Bacco F, Casanova E, Medico E, Pellegatta S, Orzan F, Albano R, Luraghi P, Reato G, D'Ambrosio A, Porrati P, Patanè M, Maderna E, Pollo B, Comoglio PM, Finocchiaro G, Boccaccio C.

Cancer Res. 2012 Sep 1;72(17):4537-50. doi: 10.1158/0008-5472.CAN-11-3490. Epub 2012 Jun 26.

Supplemental Content

Support Center